A randomized controlled trial of single-incision versus conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer

A randomized controlled trial of single-incision versus conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer - A randomized trial of SLG vs. MLG for clinical stage I gastric cancer

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022218

Enrollment

100

Registered

2016-05-09

Start date

2016-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Single-incision laparoscopic gastrectomy Multi-port laparoscopic gastrectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Histologically confirmed gastric adenocarcinoma. (2) Indication of distal gastrectomy. (3) c Stage I gastric cancer. (4) No invasion to the duodenum (5) Body mass index <30. (6) Written informed consent.

Exclusion criteria

Exclusion criteria: (1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ. (2) Women during pregnancy or breast-feeding. (3) Severe mental disease. (4) Continuous systemic steroid therapy. (5) History of myocardial infarction or unstable angina pectoris within six months. (6) Uncontrollable hypertension. (7) Uncontrollable diabetes millutus. (8) Severe respiratory disease requiring continuous oxygen therapy.

Design outcomes

Primary

Measure	Time frame
Degree of postoperative pain	—

Countries

Japan

Contacts

Public ContactTakeshi Omori

Osaka Medical Center for Cancer and Cardiovascular Diseases Gastroenterological Surgery

oomori-ta@mc.pref.osaka.jp+81669721181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026